Literature DB >> 7629502

Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas.

S Miyatake1, H Nakano, S Y Park, T Yamazaki, K Takase, H Matsushime, A Kato, T Saito.   

Abstract

The relationship between activation-induced growth inhibition and regulation of the cell cycle progression was investigated in T cell hybridomas by studying the function of the cell cycle-regulating genes such as G1 cyclins and their associated kinases. Activation of T cell hybridomas by anti-T cell receptor antibody induces growth arrest at G1 phase of the cell cycle and subsequently results in activation-driven cell death. Rapid reduction of both messenger RNA and protein level of the cyclin D3 is accompanied by growth arrest upon activation. Although the residual cyclin D3 protein forms a complex with cdk4 protein, cyclin D3-dependent kinase activity is severely impaired. Stable transfectants engineered to express cyclin D3 override the growth arrest upon activation. These results imply that the activation signal through T cell receptor induces the down-regulation of cyclin D3 expression and cyclin D3-dependent kinase activity, leading to growth arrest in G1 phase of the cell cycle in T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629502      PMCID: PMC2192146          DOI: 10.1084/jem.182.2.401

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  46 in total

Review 1.  Novel mammalian cyclins (CYL genes) expressed during G1.

Authors:  H Matsushime; M F Roussel; C J Sherr
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1991

2.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

3.  Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene.

Authors:  T Motokura; K Keyomarsi; H M Kronenberg; A Arnold
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

4.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

5.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.

Authors:  J Kato; H Matsushime; S W Hiebert; M E Ewen; C J Sherr
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

6.  Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts.

Authors:  K A Won; Y Xiong; D Beach; M Z Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  Association of human cyclin E with a periodic G1-S phase protein kinase.

Authors:  V Dulić; E Lees; S I Reed
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

8.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Authors:  H Matsushime; M E Ewen; D K Strom; J Y Kato; S K Hanks; M F Roussel; C J Sherr
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.

Authors:  F Ajchenbaum; K Ando; J A DeCaprio; J D Griffin
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

10.  A family of human cdc2-related protein kinases.

Authors:  M Meyerson; G H Enders; C L Wu; L K Su; C Gorka; C Nelson; E Harlow; L H Tsai
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  5 in total

1.  Cell cycle arrest caused by MEK/ERK signaling is a mechanism for suppressing growth of antigen-hyperstimulated effector T cells.

Authors:  Shizuka Ohtsuka; Shuhei Ogawa; Ei Wakamatsu; Ryo Abe
Journal:  Int Immunol       Date:  2016-08-19       Impact factor: 4.823

2.  Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs.

Authors:  N Kayagaki; N Yamaguchi; M Nakayama; H Eto; K Okumura; H Yagita
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

3.  Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion.

Authors:  I H Lee; W P Li; K B Hisert; L B Ivashkiv
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

4.  Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.

Authors:  H Arase; N Arase; T Saito
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

5.  miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.

Authors:  Xiaojie Yu; Yiqiang Zhang; David Cavazos; Xiuye Ma; Zhenze Zhao; Liqin Du; Alexander Pertsemlidis
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.